Ipca Laboratories
Ipca Laboratories Limited, headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry, specialising in the manufacture and export of active pharmaceutical ingredients (APIs) and finished dosage forms. Founded in 1949, the company has achieved significant milestones, including a robust presence in over 100 countries and a diverse product portfolio that encompasses a wide range of therapeutic areas such as cardiovascular, anti-infective, and pain management.
With a commitment to quality and innovation, Ipca Laboratories stands out for its extensive range of generic formulations and APIs, which are produced in state-of-the-art facilities adhering to international standards. The company has garnered a strong market position, recognised for its consistent growth and contributions to healthcare, making it a trusted name in the global pharmaceutical landscape.
+11 vs industry average
Ipca Laboratories’s score of 49 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ipca Laboratories?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Ipca Laboratories's reported carbon emissions
In 2025, Ipca Laboratories reported total carbon emissions of approximately 582,391,000 kg CO2e, comprising 169,992,000 kg CO2e from Scope 1, 124,512,000 kg CO2e from Scope 2, and 287,887,000 kg CO2e from Scope 3. This data reflects a comprehensive approach to emissions reporting, with all three scopes disclosed. The company has set ambitious targets to reduce its carbon footprint, aiming for a 20% reduction in carbon emissions from Scope 1 and Scope 2 by 2030, with the initiative having commenced in 2022. This commitment underscores Ipca's dedication to sustainability within the pharmaceuticals sector. In previous years, emissions were also significant, with totals of approximately 618,543,000 kg CO2e in 2024 and 304,994,000 kg CO2e in 2023. The company is actively working towards its reduction goals, demonstrating a proactive stance in addressing climate change and aligning with industry standards for environmental responsibility. Ipca Laboratories is committed to achieving net-zero emissions, reflecting its long-term vision for sustainability in the pharmaceutical industry.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ipca Laboratories’s Climate Goals (2030 & 2050)
2 goals2030
20% reduction in Scope 2
Carbon Emission: 20 % reduction in carbon emissions by 2030 ( scope 1 & 2 )
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Ipca Laboratories’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project